Package 0781-3476-12

Brand: fondaparinux sodium

Generic: fondaparinux sodium
NDC Package

Package Facts

Identity

Package NDC 0781-3476-12
Digits Only 0781347612
Product NDC 0781-3476
Description

2 SYRINGE in 1 CARTON (0781-3476-12) / .8 mL in 1 SYRINGE (0781-3476-94)

Marketing

Marketing Status
Marketed Since 2019-06-18
Brand fondaparinux sodium
Generic fondaparinux sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "3d5a4b69-462b-7e51-e063-6294a90a0721", "openfda": {"upc": ["0307813465126", "0307813476955", "0307813476122", "0307813465959"], "unii": ["X0Q6N9USOZ"], "rxcui": ["861356", "861360", "861363", "861365"], "spl_set_id": ["baa50757-a927-4d56-a933-5d7798fe6ab0"], "manufacturer_name": ["Sandoz Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (0781-3476-12)  / .8 mL in 1 SYRINGE (0781-3476-94)", "package_ndc": "0781-3476-12", "marketing_start_date": "20190618"}, {"sample": false, "description": "10 SYRINGE in 1 CARTON (0781-3476-95)  / .8 mL in 1 SYRINGE (0781-3476-94)", "package_ndc": "0781-3476-95", "marketing_start_date": "20190618"}], "brand_name": "Fondaparinux Sodium", "product_id": "0781-3476_3d5a4b69-462b-7e51-e063-6294a90a0721", "dosage_form": "INJECTION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "0781-3476", "generic_name": "Fondaparinux Sodium", "labeler_name": "Sandoz Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fondaparinux Sodium", "active_ingredients": [{"name": "FONDAPARINUX SODIUM", "strength": "10 mg/.8mL"}], "application_number": "ANDA206812", "marketing_category": "ANDA", "marketing_start_date": "20190618", "listing_expiration_date": "20261231"}